Pharma & Healthcare
Global Intravenous Immunoglobulin (IVIg) Market Research Report 2025
- Mar 11, 25
- ID: 30539
- Pages: 91
- Figures: 97
- Views: 13
The global market for Intravenous Immunoglobulin (IVIg) was valued at US$ 11550 million in the year 2024 and is projected to reach a revised size of US$ 17160 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.
Global Intravenous Immunoglobulin (IVIg) main players are Baxter, Grifols, CSL, Octapharma, etc. Global top four manufacturers hold a share above 65%. North America is the largest market, with a share about 45%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Intravenous Immunoglobulin (IVIg), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Immunoglobulin (IVIg).
The Intravenous Immunoglobulin (IVIg) market size, estimations, and forecasts are provided in terms of sales volume (K Bottle) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intravenous Immunoglobulin (IVIg) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravenous Immunoglobulin (IVIg) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Baxter
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
Segment by Type
IVIg Liquid
IVIg Powder
Segment by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intravenous Immunoglobulin (IVIg) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intravenous Immunoglobulin (IVIg) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or “lot” of Intravenous Immunoglobulin.
Global Intravenous Immunoglobulin (IVIg) main players are Baxter, Grifols, CSL, Octapharma, etc. Global top four manufacturers hold a share above 65%. North America is the largest market, with a share about 45%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Intravenous Immunoglobulin (IVIg), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Immunoglobulin (IVIg).
The Intravenous Immunoglobulin (IVIg) market size, estimations, and forecasts are provided in terms of sales volume (K Bottle) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intravenous Immunoglobulin (IVIg) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravenous Immunoglobulin (IVIg) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Baxter
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
Segment by Type
IVIg Liquid
IVIg Powder
Segment by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intravenous Immunoglobulin (IVIg) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intravenous Immunoglobulin (IVIg) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Intravenous Immunoglobulin (IVIg) Market Overview
1.1 Product Definition
1.2 Intravenous Immunoglobulin (IVIg) by Type
1.2.1 Global Intravenous Immunoglobulin (IVIg) Market Value Comparison by Type (2024 VS 2031)
1.2.2 IVIg Liquid
1.2.3 IVIg Powder
1.3 Intravenous Immunoglobulin (IVIg) by Application
1.3.1 Global Intravenous Immunoglobulin (IVIg) Market Value by Application (2024 VS 2031)
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Global Intravenous Immunoglobulin (IVIg) Market Size Estimates and Forecasts
1.4.1 Global Intravenous Immunoglobulin (IVIg) Revenue 2020-2031
1.4.2 Global Intravenous Immunoglobulin (IVIg) Sales 2020-2031
1.4.3 Global Intravenous Immunoglobulin (IVIg) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Intravenous Immunoglobulin (IVIg) Market Competition by Manufacturers
2.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Intravenous Immunoglobulin (IVIg) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Intravenous Immunoglobulin (IVIg), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intravenous Immunoglobulin (IVIg), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intravenous Immunoglobulin (IVIg), Product Type & Application
2.7 Global Key Manufacturers of Intravenous Immunoglobulin (IVIg), Date of Enter into This Industry
2.8 Global Intravenous Immunoglobulin (IVIg) Market Competitive Situation and Trends
2.8.1 Global Intravenous Immunoglobulin (IVIg) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Intravenous Immunoglobulin (IVIg) Players Market Share by Revenue
2.8.3 Global Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Intravenous Immunoglobulin (IVIg) Market Scenario by Region
3.1 Global Intravenous Immunoglobulin (IVIg) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Intravenous Immunoglobulin (IVIg) Sales by Region: 2020-2031
3.2.1 Global Intravenous Immunoglobulin (IVIg) Sales by Region: 2020-2025
3.2.2 Global Intravenous Immunoglobulin (IVIg) Sales by Region: 2026-2031
3.3 Global Intravenous Immunoglobulin (IVIg) Revenue by Region: 2020-2031
3.3.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Region: 2020-2025
3.3.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Region: 2026-2031
3.4 North America Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
3.4.1 North America Intravenous Immunoglobulin (IVIg) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Intravenous Immunoglobulin (IVIg) Sales by Country (2020-2031)
3.4.3 North America Intravenous Immunoglobulin (IVIg) Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
3.5.1 Europe Intravenous Immunoglobulin (IVIg) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2020-2031)
3.5.3 Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Region
3.6.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Region (2020-2031)
3.6.3 Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
3.7.1 Latin America Intravenous Immunoglobulin (IVIg) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (2020-2031)
3.7.3 Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
3.8.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intravenous Immunoglobulin (IVIg) Sales by Type (2020-2031)
4.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Type (2020-2025)
4.1.2 Global Intravenous Immunoglobulin (IVIg) Sales by Type (2026-2031)
4.1.3 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2020-2031)
4.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2020-2031)
4.2.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2020-2025)
4.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2026-2031)
4.2.3 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2020-2031)
4.3 Global Intravenous Immunoglobulin (IVIg) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Intravenous Immunoglobulin (IVIg) Sales by Application (2020-2031)
5.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Application (2020-2025)
5.1.2 Global Intravenous Immunoglobulin (IVIg) Sales by Application (2026-2031)
5.1.3 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2020-2031)
5.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2020-2031)
5.2.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2020-2025)
5.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2026-2031)
5.2.3 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2020-2031)
5.3 Global Intravenous Immunoglobulin (IVIg) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Company Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Baxter Intravenous Immunoglobulin (IVIg) Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Company Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Grifols Intravenous Immunoglobulin (IVIg) Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 CSL
6.3.1 CSL Company Information
6.3.2 CSL Description and Business Overview
6.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 CSL Intravenous Immunoglobulin (IVIg) Product Portfolio
6.3.5 CSL Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Company Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Biotest
6.5.1 Biotest Company Information
6.5.2 Biotest Description and Business Overview
6.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Biotest Intravenous Immunoglobulin (IVIg) Product Portfolio
6.5.5 Biotest Recent Developments/Updates
6.6 Kedrion
6.6.1 Kedrion Company Information
6.6.2 Kedrion Description and Business Overview
6.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Kedrion Intravenous Immunoglobulin (IVIg) Product Portfolio
6.6.5 Kedrion Recent Developments/Updates
6.7 Hualan Bio
6.7.1 Hualan Bio Company Information
6.7.2 Hualan Bio Description and Business Overview
6.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Product Portfolio
6.7.5 Hualan Bio Recent Developments/Updates
6.8 CNBG
6.8.1 CNBG Company Information
6.8.2 CNBG Description and Business Overview
6.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 CNBG Intravenous Immunoglobulin (IVIg) Product Portfolio
6.8.5 CNBG Recent Developments/Updates
6.9 Shanghai RAAS
6.9.1 Shanghai RAAS Company Information
6.9.2 Shanghai RAAS Description and Business Overview
6.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Portfolio
6.9.5 Shanghai RAAS Recent Developments/Updates
6.10 CBPO
6.10.1 CBPO Company Information
6.10.2 CBPO Description and Business Overview
6.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 CBPO Intravenous Immunoglobulin (IVIg) Product Portfolio
6.10.5 CBPO Recent Developments/Updates
6.11 LFB Group
6.11.1 LFB Group Company Information
6.11.2 LFB Group Description and Business Overview
6.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 LFB Group Intravenous Immunoglobulin (IVIg) Product Portfolio
6.11.5 LFB Group Recent Developments/Updates
6.12 BPL
6.12.1 BPL Company Information
6.12.2 BPL Description and Business Overview
6.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
6.12.4 BPL Intravenous Immunoglobulin (IVIg) Product Portfolio
6.12.5 BPL Recent Developments/Updates
6.13 Sichuan Yuanda Shuyang
6.13.1 Sichuan Yuanda Shuyang Company Information
6.13.2 Sichuan Yuanda Shuyang Description and Business Overview
6.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Portfolio
6.13.5 Sichuan Yuanda Shuyang Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intravenous Immunoglobulin (IVIg) Industry Chain Analysis
7.2 Intravenous Immunoglobulin (IVIg) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intravenous Immunoglobulin (IVIg) Production Mode & Process Analysis
7.4 Intravenous Immunoglobulin (IVIg) Sales and Marketing
7.4.1 Intravenous Immunoglobulin (IVIg) Sales Channels
7.4.2 Intravenous Immunoglobulin (IVIg) Distributors
7.5 Intravenous Immunoglobulin (IVIg) Customer Analysis
8 Intravenous Immunoglobulin (IVIg) Market Dynamics
8.1 Intravenous Immunoglobulin (IVIg) Industry Trends
8.2 Intravenous Immunoglobulin (IVIg) Market Drivers
8.3 Intravenous Immunoglobulin (IVIg) Market Challenges
8.4 Intravenous Immunoglobulin (IVIg) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Intravenous Immunoglobulin (IVIg) by Type
1.2.1 Global Intravenous Immunoglobulin (IVIg) Market Value Comparison by Type (2024 VS 2031)
1.2.2 IVIg Liquid
1.2.3 IVIg Powder
1.3 Intravenous Immunoglobulin (IVIg) by Application
1.3.1 Global Intravenous Immunoglobulin (IVIg) Market Value by Application (2024 VS 2031)
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Global Intravenous Immunoglobulin (IVIg) Market Size Estimates and Forecasts
1.4.1 Global Intravenous Immunoglobulin (IVIg) Revenue 2020-2031
1.4.2 Global Intravenous Immunoglobulin (IVIg) Sales 2020-2031
1.4.3 Global Intravenous Immunoglobulin (IVIg) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Intravenous Immunoglobulin (IVIg) Market Competition by Manufacturers
2.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Intravenous Immunoglobulin (IVIg) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Intravenous Immunoglobulin (IVIg), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intravenous Immunoglobulin (IVIg), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intravenous Immunoglobulin (IVIg), Product Type & Application
2.7 Global Key Manufacturers of Intravenous Immunoglobulin (IVIg), Date of Enter into This Industry
2.8 Global Intravenous Immunoglobulin (IVIg) Market Competitive Situation and Trends
2.8.1 Global Intravenous Immunoglobulin (IVIg) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Intravenous Immunoglobulin (IVIg) Players Market Share by Revenue
2.8.3 Global Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Intravenous Immunoglobulin (IVIg) Market Scenario by Region
3.1 Global Intravenous Immunoglobulin (IVIg) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Intravenous Immunoglobulin (IVIg) Sales by Region: 2020-2031
3.2.1 Global Intravenous Immunoglobulin (IVIg) Sales by Region: 2020-2025
3.2.2 Global Intravenous Immunoglobulin (IVIg) Sales by Region: 2026-2031
3.3 Global Intravenous Immunoglobulin (IVIg) Revenue by Region: 2020-2031
3.3.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Region: 2020-2025
3.3.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Region: 2026-2031
3.4 North America Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
3.4.1 North America Intravenous Immunoglobulin (IVIg) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Intravenous Immunoglobulin (IVIg) Sales by Country (2020-2031)
3.4.3 North America Intravenous Immunoglobulin (IVIg) Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
3.5.1 Europe Intravenous Immunoglobulin (IVIg) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2020-2031)
3.5.3 Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Region
3.6.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Region (2020-2031)
3.6.3 Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
3.7.1 Latin America Intravenous Immunoglobulin (IVIg) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (2020-2031)
3.7.3 Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
3.8.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intravenous Immunoglobulin (IVIg) Sales by Type (2020-2031)
4.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Type (2020-2025)
4.1.2 Global Intravenous Immunoglobulin (IVIg) Sales by Type (2026-2031)
4.1.3 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2020-2031)
4.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2020-2031)
4.2.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2020-2025)
4.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2026-2031)
4.2.3 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2020-2031)
4.3 Global Intravenous Immunoglobulin (IVIg) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Intravenous Immunoglobulin (IVIg) Sales by Application (2020-2031)
5.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Application (2020-2025)
5.1.2 Global Intravenous Immunoglobulin (IVIg) Sales by Application (2026-2031)
5.1.3 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2020-2031)
5.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2020-2031)
5.2.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2020-2025)
5.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2026-2031)
5.2.3 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2020-2031)
5.3 Global Intravenous Immunoglobulin (IVIg) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Company Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Baxter Intravenous Immunoglobulin (IVIg) Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Company Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Grifols Intravenous Immunoglobulin (IVIg) Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 CSL
6.3.1 CSL Company Information
6.3.2 CSL Description and Business Overview
6.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 CSL Intravenous Immunoglobulin (IVIg) Product Portfolio
6.3.5 CSL Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Company Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Biotest
6.5.1 Biotest Company Information
6.5.2 Biotest Description and Business Overview
6.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Biotest Intravenous Immunoglobulin (IVIg) Product Portfolio
6.5.5 Biotest Recent Developments/Updates
6.6 Kedrion
6.6.1 Kedrion Company Information
6.6.2 Kedrion Description and Business Overview
6.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Kedrion Intravenous Immunoglobulin (IVIg) Product Portfolio
6.6.5 Kedrion Recent Developments/Updates
6.7 Hualan Bio
6.7.1 Hualan Bio Company Information
6.7.2 Hualan Bio Description and Business Overview
6.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Product Portfolio
6.7.5 Hualan Bio Recent Developments/Updates
6.8 CNBG
6.8.1 CNBG Company Information
6.8.2 CNBG Description and Business Overview
6.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 CNBG Intravenous Immunoglobulin (IVIg) Product Portfolio
6.8.5 CNBG Recent Developments/Updates
6.9 Shanghai RAAS
6.9.1 Shanghai RAAS Company Information
6.9.2 Shanghai RAAS Description and Business Overview
6.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Portfolio
6.9.5 Shanghai RAAS Recent Developments/Updates
6.10 CBPO
6.10.1 CBPO Company Information
6.10.2 CBPO Description and Business Overview
6.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 CBPO Intravenous Immunoglobulin (IVIg) Product Portfolio
6.10.5 CBPO Recent Developments/Updates
6.11 LFB Group
6.11.1 LFB Group Company Information
6.11.2 LFB Group Description and Business Overview
6.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 LFB Group Intravenous Immunoglobulin (IVIg) Product Portfolio
6.11.5 LFB Group Recent Developments/Updates
6.12 BPL
6.12.1 BPL Company Information
6.12.2 BPL Description and Business Overview
6.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
6.12.4 BPL Intravenous Immunoglobulin (IVIg) Product Portfolio
6.12.5 BPL Recent Developments/Updates
6.13 Sichuan Yuanda Shuyang
6.13.1 Sichuan Yuanda Shuyang Company Information
6.13.2 Sichuan Yuanda Shuyang Description and Business Overview
6.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Portfolio
6.13.5 Sichuan Yuanda Shuyang Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intravenous Immunoglobulin (IVIg) Industry Chain Analysis
7.2 Intravenous Immunoglobulin (IVIg) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intravenous Immunoglobulin (IVIg) Production Mode & Process Analysis
7.4 Intravenous Immunoglobulin (IVIg) Sales and Marketing
7.4.1 Intravenous Immunoglobulin (IVIg) Sales Channels
7.4.2 Intravenous Immunoglobulin (IVIg) Distributors
7.5 Intravenous Immunoglobulin (IVIg) Customer Analysis
8 Intravenous Immunoglobulin (IVIg) Market Dynamics
8.1 Intravenous Immunoglobulin (IVIg) Industry Trends
8.2 Intravenous Immunoglobulin (IVIg) Market Drivers
8.3 Intravenous Immunoglobulin (IVIg) Market Challenges
8.4 Intravenous Immunoglobulin (IVIg) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Intravenous Immunoglobulin (IVIg) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Intravenous Immunoglobulin (IVIg) Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Intravenous Immunoglobulin (IVIg) Market Competitive Situation by Manufacturers in 2024
Table 4. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) of Key Manufacturers (2020-2025)
Table 5. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Intravenous Immunoglobulin (IVIg) Average Price (USD/Bottle) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Intravenous Immunoglobulin (IVIg), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Intravenous Immunoglobulin (IVIg), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Intravenous Immunoglobulin (IVIg), Product Type & Application
Table 12. Global Key Manufacturers of Intravenous Immunoglobulin (IVIg), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Intravenous Immunoglobulin (IVIg) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Immunoglobulin (IVIg) as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Intravenous Immunoglobulin (IVIg) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Intravenous Immunoglobulin (IVIg) Sales by Region (2020-2025) & (K Bottle)
Table 18. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2020-2025)
Table 19. Global Intravenous Immunoglobulin (IVIg) Sales by Region (2026-2031) & (K Bottle)
Table 20. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2026-2031)
Table 21. Global Intravenous Immunoglobulin (IVIg) Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2020-2025)
Table 23. Global Intravenous Immunoglobulin (IVIg) Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2026-2031)
Table 25. North America Intravenous Immunoglobulin (IVIg) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Intravenous Immunoglobulin (IVIg) Sales by Country (2020-2025) & (K Bottle)
Table 27. North America Intravenous Immunoglobulin (IVIg) Sales by Country (2026-2031) & (K Bottle)
Table 28. North America Intravenous Immunoglobulin (IVIg) Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Intravenous Immunoglobulin (IVIg) Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Intravenous Immunoglobulin (IVIg) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2020-2025) & (K Bottle)
Table 32. Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2026-2031) & (K Bottle)
Table 33. Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Region (2020-2025) & (K Bottle)
Table 37. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Region (2026-2031) & (K Bottle)
Table 38. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (2020-2025) & (K Bottle)
Table 42. Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (2026-2031) & (K Bottle)
Table 43. Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2020-2025) & (K Bottle)
Table 47. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2026-2031) & (K Bottle)
Table 48. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Type (2020-2025)
Table 51. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Type (2026-2031)
Table 52. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2020-2025)
Table 53. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2026-2031)
Table 54. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2020-2025)
Table 57. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2026-2031)
Table 58. Global Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Type (2020-2025)
Table 59. Global Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Type (2026-2031)
Table 60. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Application (2020-2025)
Table 61. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Application (2026-2031)
Table 62. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2020-2025)
Table 63. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2026-2031)
Table 64. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2020-2025)
Table 67. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2026-2031)
Table 68. Global Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Application (2020-2025)
Table 69. Global Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Application (2026-2031)
Table 70. Baxter Company Information
Table 71. Baxter Description and Business Overview
Table 72. Baxter Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 73. Baxter Intravenous Immunoglobulin (IVIg) Product
Table 74. Baxter Recent Developments/Updates
Table 75. Grifols Company Information
Table 76. Grifols Description and Business Overview
Table 77. Grifols Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 78. Grifols Intravenous Immunoglobulin (IVIg) Product
Table 79. Grifols Recent Developments/Updates
Table 80. CSL Company Information
Table 81. CSL Description and Business Overview
Table 82. CSL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 83. CSL Intravenous Immunoglobulin (IVIg) Product
Table 84. CSL Recent Developments/Updates
Table 85. Octapharma Company Information
Table 86. Octapharma Description and Business Overview
Table 87. Octapharma Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 88. Octapharma Intravenous Immunoglobulin (IVIg) Product
Table 89. Octapharma Recent Developments/Updates
Table 90. Biotest Company Information
Table 91. Biotest Description and Business Overview
Table 92. Biotest Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 93. Biotest Intravenous Immunoglobulin (IVIg) Product
Table 94. Biotest Recent Developments/Updates
Table 95. Kedrion Company Information
Table 96. Kedrion Description and Business Overview
Table 97. Kedrion Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 98. Kedrion Intravenous Immunoglobulin (IVIg) Product
Table 99. Kedrion Recent Developments/Updates
Table 100. Hualan Bio Company Information
Table 101. Hualan Bio Description and Business Overview
Table 102. Hualan Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 103. Hualan Bio Intravenous Immunoglobulin (IVIg) Product
Table 104. Hualan Bio Recent Developments/Updates
Table 105. CNBG Company Information
Table 106. CNBG Description and Business Overview
Table 107. CNBG Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 108. CNBG Intravenous Immunoglobulin (IVIg) Product
Table 109. CNBG Recent Developments/Updates
Table 110. Shanghai RAAS Company Information
Table 111. Shanghai RAAS Description and Business Overview
Table 112. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 113. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product
Table 114. Shanghai RAAS Recent Developments/Updates
Table 115. CBPO Company Information
Table 116. CBPO Description and Business Overview
Table 117. CBPO Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 118. CBPO Intravenous Immunoglobulin (IVIg) Product
Table 119. CBPO Recent Developments/Updates
Table 120. LFB Group Company Information
Table 121. LFB Group Description and Business Overview
Table 122. LFB Group Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 123. LFB Group Intravenous Immunoglobulin (IVIg) Product
Table 124. LFB Group Recent Developments/Updates
Table 125. BPL Company Information
Table 126. BPL Description and Business Overview
Table 127. BPL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 128. BPL Intravenous Immunoglobulin (IVIg) Product
Table 129. BPL Recent Developments/Updates
Table 130. Sichuan Yuanda Shuyang Company Information
Table 131. Sichuan Yuanda Shuyang Description and Business Overview
Table 132. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 133. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product
Table 134. Sichuan Yuanda Shuyang Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Intravenous Immunoglobulin (IVIg) Distributors List
Table 138. Intravenous Immunoglobulin (IVIg) Customers List
Table 139. Intravenous Immunoglobulin (IVIg) Market Trends
Table 140. Intravenous Immunoglobulin (IVIg) Market Drivers
Table 141. Intravenous Immunoglobulin (IVIg) Market Challenges
Table 142. Intravenous Immunoglobulin (IVIg) Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Intravenous Immunoglobulin (IVIg)
Figure 2. Global Intravenous Immunoglobulin (IVIg) Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Intravenous Immunoglobulin (IVIg) Market Share by Type: 2024 & 2031
Figure 4. IVIg Liquid Product Picture
Figure 5. IVIg Powder Product Picture
Figure 6. Global Intravenous Immunoglobulin (IVIg) Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Intravenous Immunoglobulin (IVIg) Market Share by Application: 2024 & 2031
Figure 8. Immunodeficiency
Figure 9. Autoimmune Disease
Figure 10. Acute Infection
Figure 11. Global Intravenous Immunoglobulin (IVIg) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Intravenous Immunoglobulin (IVIg) Market Size (2020-2031) & (US$ Million)
Figure 13. Global Intravenous Immunoglobulin (IVIg) Sales (2020-2031) & (K Bottle)
Figure 14. Global Intravenous Immunoglobulin (IVIg) Average Price (USD/Bottle) & (2020-2031)
Figure 15. Intravenous Immunoglobulin (IVIg) Report Years Considered
Figure 16. Intravenous Immunoglobulin (IVIg) Sales Share by Manufacturers in 2024
Figure 17. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Intravenous Immunoglobulin (IVIg) Players: Market Share by Revenue in Intravenous Immunoglobulin (IVIg) in 2024
Figure 19. Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Intravenous Immunoglobulin (IVIg) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2020-2031)
Figure 22. North America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2020-2031)
Figure 26. Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2020-2031)
Figure 27. Germany Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2020-2031)
Figure 34. China Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2020-2031)
Figure 44. Latin America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Intravenous Immunoglobulin (IVIg) by Type (2020-2031)
Figure 54. Global Revenue Market Share of Intravenous Immunoglobulin (IVIg) by Type (2020-2031)
Figure 55. Global Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Type (2020-2031)
Figure 56. Global Sales Market Share of Intravenous Immunoglobulin (IVIg) by Application (2020-2031)
Figure 57. Global Revenue Market Share of Intravenous Immunoglobulin (IVIg) by Application (2020-2031)
Figure 58. Global Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Application (2020-2031)
Figure 59. Intravenous Immunoglobulin (IVIg) Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Intravenous Immunoglobulin (IVIg) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Intravenous Immunoglobulin (IVIg) Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Intravenous Immunoglobulin (IVIg) Market Competitive Situation by Manufacturers in 2024
Table 4. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) of Key Manufacturers (2020-2025)
Table 5. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Intravenous Immunoglobulin (IVIg) Average Price (USD/Bottle) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Intravenous Immunoglobulin (IVIg), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Intravenous Immunoglobulin (IVIg), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Intravenous Immunoglobulin (IVIg), Product Type & Application
Table 12. Global Key Manufacturers of Intravenous Immunoglobulin (IVIg), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Intravenous Immunoglobulin (IVIg) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Immunoglobulin (IVIg) as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Intravenous Immunoglobulin (IVIg) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Intravenous Immunoglobulin (IVIg) Sales by Region (2020-2025) & (K Bottle)
Table 18. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2020-2025)
Table 19. Global Intravenous Immunoglobulin (IVIg) Sales by Region (2026-2031) & (K Bottle)
Table 20. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2026-2031)
Table 21. Global Intravenous Immunoglobulin (IVIg) Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2020-2025)
Table 23. Global Intravenous Immunoglobulin (IVIg) Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2026-2031)
Table 25. North America Intravenous Immunoglobulin (IVIg) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Intravenous Immunoglobulin (IVIg) Sales by Country (2020-2025) & (K Bottle)
Table 27. North America Intravenous Immunoglobulin (IVIg) Sales by Country (2026-2031) & (K Bottle)
Table 28. North America Intravenous Immunoglobulin (IVIg) Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Intravenous Immunoglobulin (IVIg) Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Intravenous Immunoglobulin (IVIg) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2020-2025) & (K Bottle)
Table 32. Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2026-2031) & (K Bottle)
Table 33. Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Region (2020-2025) & (K Bottle)
Table 37. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Region (2026-2031) & (K Bottle)
Table 38. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (2020-2025) & (K Bottle)
Table 42. Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (2026-2031) & (K Bottle)
Table 43. Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2020-2025) & (K Bottle)
Table 47. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2026-2031) & (K Bottle)
Table 48. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Type (2020-2025)
Table 51. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Type (2026-2031)
Table 52. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2020-2025)
Table 53. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2026-2031)
Table 54. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2020-2025)
Table 57. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2026-2031)
Table 58. Global Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Type (2020-2025)
Table 59. Global Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Type (2026-2031)
Table 60. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Application (2020-2025)
Table 61. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Application (2026-2031)
Table 62. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2020-2025)
Table 63. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2026-2031)
Table 64. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Intravenous Immunoglobulin (IVIg) Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2020-2025)
Table 67. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2026-2031)
Table 68. Global Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Application (2020-2025)
Table 69. Global Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Application (2026-2031)
Table 70. Baxter Company Information
Table 71. Baxter Description and Business Overview
Table 72. Baxter Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 73. Baxter Intravenous Immunoglobulin (IVIg) Product
Table 74. Baxter Recent Developments/Updates
Table 75. Grifols Company Information
Table 76. Grifols Description and Business Overview
Table 77. Grifols Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 78. Grifols Intravenous Immunoglobulin (IVIg) Product
Table 79. Grifols Recent Developments/Updates
Table 80. CSL Company Information
Table 81. CSL Description and Business Overview
Table 82. CSL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 83. CSL Intravenous Immunoglobulin (IVIg) Product
Table 84. CSL Recent Developments/Updates
Table 85. Octapharma Company Information
Table 86. Octapharma Description and Business Overview
Table 87. Octapharma Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 88. Octapharma Intravenous Immunoglobulin (IVIg) Product
Table 89. Octapharma Recent Developments/Updates
Table 90. Biotest Company Information
Table 91. Biotest Description and Business Overview
Table 92. Biotest Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 93. Biotest Intravenous Immunoglobulin (IVIg) Product
Table 94. Biotest Recent Developments/Updates
Table 95. Kedrion Company Information
Table 96. Kedrion Description and Business Overview
Table 97. Kedrion Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 98. Kedrion Intravenous Immunoglobulin (IVIg) Product
Table 99. Kedrion Recent Developments/Updates
Table 100. Hualan Bio Company Information
Table 101. Hualan Bio Description and Business Overview
Table 102. Hualan Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 103. Hualan Bio Intravenous Immunoglobulin (IVIg) Product
Table 104. Hualan Bio Recent Developments/Updates
Table 105. CNBG Company Information
Table 106. CNBG Description and Business Overview
Table 107. CNBG Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 108. CNBG Intravenous Immunoglobulin (IVIg) Product
Table 109. CNBG Recent Developments/Updates
Table 110. Shanghai RAAS Company Information
Table 111. Shanghai RAAS Description and Business Overview
Table 112. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 113. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product
Table 114. Shanghai RAAS Recent Developments/Updates
Table 115. CBPO Company Information
Table 116. CBPO Description and Business Overview
Table 117. CBPO Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 118. CBPO Intravenous Immunoglobulin (IVIg) Product
Table 119. CBPO Recent Developments/Updates
Table 120. LFB Group Company Information
Table 121. LFB Group Description and Business Overview
Table 122. LFB Group Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 123. LFB Group Intravenous Immunoglobulin (IVIg) Product
Table 124. LFB Group Recent Developments/Updates
Table 125. BPL Company Information
Table 126. BPL Description and Business Overview
Table 127. BPL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 128. BPL Intravenous Immunoglobulin (IVIg) Product
Table 129. BPL Recent Developments/Updates
Table 130. Sichuan Yuanda Shuyang Company Information
Table 131. Sichuan Yuanda Shuyang Description and Business Overview
Table 132. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 133. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product
Table 134. Sichuan Yuanda Shuyang Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Intravenous Immunoglobulin (IVIg) Distributors List
Table 138. Intravenous Immunoglobulin (IVIg) Customers List
Table 139. Intravenous Immunoglobulin (IVIg) Market Trends
Table 140. Intravenous Immunoglobulin (IVIg) Market Drivers
Table 141. Intravenous Immunoglobulin (IVIg) Market Challenges
Table 142. Intravenous Immunoglobulin (IVIg) Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Intravenous Immunoglobulin (IVIg)
Figure 2. Global Intravenous Immunoglobulin (IVIg) Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Intravenous Immunoglobulin (IVIg) Market Share by Type: 2024 & 2031
Figure 4. IVIg Liquid Product Picture
Figure 5. IVIg Powder Product Picture
Figure 6. Global Intravenous Immunoglobulin (IVIg) Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Intravenous Immunoglobulin (IVIg) Market Share by Application: 2024 & 2031
Figure 8. Immunodeficiency
Figure 9. Autoimmune Disease
Figure 10. Acute Infection
Figure 11. Global Intravenous Immunoglobulin (IVIg) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Intravenous Immunoglobulin (IVIg) Market Size (2020-2031) & (US$ Million)
Figure 13. Global Intravenous Immunoglobulin (IVIg) Sales (2020-2031) & (K Bottle)
Figure 14. Global Intravenous Immunoglobulin (IVIg) Average Price (USD/Bottle) & (2020-2031)
Figure 15. Intravenous Immunoglobulin (IVIg) Report Years Considered
Figure 16. Intravenous Immunoglobulin (IVIg) Sales Share by Manufacturers in 2024
Figure 17. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Intravenous Immunoglobulin (IVIg) Players: Market Share by Revenue in Intravenous Immunoglobulin (IVIg) in 2024
Figure 19. Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Intravenous Immunoglobulin (IVIg) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2020-2031)
Figure 22. North America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2020-2031)
Figure 26. Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2020-2031)
Figure 27. Germany Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2020-2031)
Figure 34. China Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2020-2031)
Figure 44. Latin America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Intravenous Immunoglobulin (IVIg) by Type (2020-2031)
Figure 54. Global Revenue Market Share of Intravenous Immunoglobulin (IVIg) by Type (2020-2031)
Figure 55. Global Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Type (2020-2031)
Figure 56. Global Sales Market Share of Intravenous Immunoglobulin (IVIg) by Application (2020-2031)
Figure 57. Global Revenue Market Share of Intravenous Immunoglobulin (IVIg) by Application (2020-2031)
Figure 58. Global Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Application (2020-2031)
Figure 59. Intravenous Immunoglobulin (IVIg) Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Benzyltrimethylammonium Hydroxide (BTMAH) Market Research Report 2025
Jul 10, 25
Global Allyltrimethylammonium Chloride Market Research Report 2025
Jul 10, 25
Global Calcium Bisglycinate Market Research Report 2025
Jul 10, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232